Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Alleva Lawrence M, Director. Officer active across 4 companies, notably Adaptimmune Therapeutics PLC. Aggregated, 16 disclosures have been logged. Split: 3 buys · 1 sell. Total volume traded: €104k. History available since 1 June 2021. The latest transaction was filed on 1 December 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Alleva Lawrence M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4,045 shares@ US$8.5887100.0% of flowCommon StockSEC:0000899243-21-021824:0
Canonical exit: 30 Aug 2021 (T+90)
16 of 16 declarations
About Alleva Lawrence M
Alleva Lawrence M is Administrateur. He has 14 filings in total. Among the sampled recent filings, buy volume is EUR 48764 and sell volume is EUR 55304, from 2021-06-03 to 2026-06-05. The modal transaction nature is Attribution.